S. R. GRATZ ;
M. ZELLER ;
D. W. MINCEY ;
C. L. FLURER
|
2009
Dans Journal of Pharmaceutical and Biomedical Analysis (Vol.50, n°2, September 2009) Article : Périodique
Dans Journal of Pharmaceutical and Biomedical Analysis (Vol.50, n°2, September 2009) Article : Périodique
Phosphodiesterase type 5 (PDE-5) inhibitors represent a class of drugs used primarily in the treatment of erectile dysfunction. Currently, three PDE-5 inhibitors have been approved by the U.S. Food and Drug Administration (FDA) for use in the Un[...]
Historique